Amgen

Regeneron CEO says Amgen not putting patients first in patent dispute
Yahoo/Reuters
Tue, 01/10/17 - 09:19 am
Regeneron
Pharma CEOs
Amgen
Sanofi
patents
Repatha
Praluent
Len Schleifer
Amgen, Immatics In Cancer Drug Partnership
Investopedia
Mon, 01/9/17 - 10:10 am
Amgen
Immatics
bispecific antibodies
R&D
cancer
Judge’s unusual ruling on Amgen, Regeneron patent case puts billions of dollars at stake
Marketwatch
Sun, 01/8/17 - 03:32 pm
Amgen
Sanofi
Regeneron
Repatha
Praluent
Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection
Yahoo
Fri, 01/6/17 - 10:22 am
Regeneron
Sanofi
Amgen
patents
Repatha
Praluent
Amgen Wins Ban on Sanofi’s Praluent Cholesterol Drug Sales
Bloomberg
Fri, 01/6/17 - 09:51 am
Amgen
Sanofi
Regeneron
Praluent
Repatha
patents
Valeant Is A Strong Acquisition Target
Seeking Alpha
Thu, 01/5/17 - 09:36 am
Valeant Pharmaceuticals
M&A
Gilead Sciences
Pfizer
Amgen
Sanofi, Regeneron one step closer to owing PCSK9 royalties as judge upholds Amgen patent ruling
Fierce Pharma
Thu, 01/5/17 - 09:20 am
Sanofi
Regeneron
PCSK9 inhibitors
Amgen
Praluent
Repatha
Biotech Stocks: What to Watch in 2017
Motley Fool
Tue, 01/3/17 - 10:02 am
biotech
M&A
drug launches
Gilead Sciences
Incyte
Spinraza
Biogen
Ionis Pharmaceuticals
Amgen
Regeneron
Sanofi
Amgen: Opportunity May Be Knocking
Yahoo/GuruFocus
Mon, 01/2/17 - 11:45 am
Amgen
Enbrel Sales Were Flat in 3Q16
Market Realist
Thu, 12/29/16 - 10:14 am
Enbrel
Amgen
Why Is Enbrel So Important for Amgen?
Marketwatch
Wed, 12/28/16 - 11:50 am
Amgen
Enbrel
What’s Behind the Decline in Amgen’s Maturing Products in 3Q16?
Market Realist
Wed, 12/28/16 - 11:01 am
Amgen
Amgen wins recommendation for single injection Repatha device
Mass Device
Tue, 12/20/16 - 12:25 pm
Amgen
Repatha
Europe
devices
Amgen, Regeneron May Yet Get Rich From Their Cholesterol Drugs
Seeking Alpha
Tue, 12/20/16 - 12:04 pm
Amgen
Regeneron
Praluent
Repatha
Sanofi
Amgen, Allergan Seek EU OK for Avastin Biosimilar
Investopedia
Mon, 12/5/16 - 09:59 am
Amgen
Allergan
Avastin
biosimilars
Europe
ABP 215
non-squamous lung cancer
Amgen eyes spending caps to win payer nods on migraine prospect erenumab
Fierce Pharma
Mon, 11/21/16 - 11:31 am
Amgen
migraines
payers
erenumab
Amgen's migraine drug succeeds in late-stage trial
Yahoo/Reuters
Wed, 11/16/16 - 09:52 pm
Amgen
migraines
erenumab
Amgen, Allergan step up to challenge Roche's Avastin with FDA biosim filing
Fierce Pharma
Wed, 11/16/16 - 09:57 am
Amgen
Allergan
Roche
Avastin
biosimilars
FDA
ABP 215
Is Amgen still shooting blanks in its war with payers over Repatha reimbursement?
Endpoints
Wed, 11/16/16 - 09:55 am
Amgen
Repatha
payers
reimbursement
Amgen cholesterol drug reduces artery-clogging plaque in study
Yahoo/Reuters
Wed, 11/16/16 - 09:48 am
Amgen
Repatha
clinical trials

Pages